Search
OrthoPediatrics Corp
KIDSAdd to Watchlist
19.950USD
+0.650+3.37%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
510.82MMarket Cap
LossP/E TTM
More Details of OrthoPediatrics Corp Company
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
OrthoPediatrics Corp Info
Ticker SymbolKIDS
Company nameOrthoPediatrics Corp
IPO dateOct 12, 2017
CEOBailey (David R)
Number of employees562
Security typeOrdinary Share
Fiscal year-endOct 12
Address2850 Frontier Drive
CityWARSAW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code46582
Phone15742686379
Websitehttps://www.orthopediatrics.com/
Ticker SymbolKIDS
IPO dateOct 12, 2017
CEOBailey (David R)
Company Executives of OrthoPediatrics Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
32.66K
+35.01%
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
31.86K
+35.90%
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
31.20K
+36.65%
Ms. Kelly Fischer
Ms. Kelly Fischer
Director
Director
15.78K
+72.47%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
FAQs
Who are the top five shareholders of OrthoPediatrics Corp?
The top five shareholders of OrthoPediatrics Corp are: Mr. David R. Bailey
How many institutions hold shares of OrthoPediatrics Corp (KIDS)?
As of 2026Q1, 287 institutions hold shares of OrthoPediatrics Corp, with a combined market value of approximately 18.35M, accounting for 71.44% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -360870.00.
What is the biggest source of revenue for OrthoPediatrics Corp?
In 2026Q1, the Trauma and Deformity business generated the highest revenue for OrthoPediatrics Corp, amounting to 166.30M and accounting for 70.36% of total revenue.